title: Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled--MS arising during Tocilizumab therapy for rheumatoid arthritis.
abstract: This clinical commentary discusses on the potential relationship between multiple sclerosis (MS) and tocilizumab in a patient with rheumatoid arthritis who developed MS while on treatment with this anti-interleukin-6 agent.
authors.affiliation: Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron (HUVH), Universitat Autònoma de Barcelona, Barcelona, Spain manuel.comabella@vhir.org.
authors.forename: Manuel
authors.initials: M
authors.lastname: Comabella
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid; D006801:Humans; D015850:Interleukin-6; D009103:Multiple Sclerosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015850:Interleukin-6; C502936:tocilizumab
keywords: Tocilizumab; multiple sclerosis; rheumatoid arthritis